Impact Biomedical (IBO) Depreciation & Amortization - Total (2023 - 2025)

Impact Biomedical (IBO) has reported Depreciation & Amortization - Total for 3 consecutive years, with $2000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization - Total changed 0.0% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2025 stood at $6000.0 (down 14.29% YoY), and the FY2025 full-year result was $6000.0, down 14.29% from the prior year.
• Depreciation & Amortization - Total grew to $2000.0 in Q4 2025 per IBO's latest filing, from $1000.0 in the prior quarter.
• Across five years, Depreciation & Amortization - Total topped out at $2000.0 in Q1 2023 and bottomed at $1000.0 in Q2 2023.
• Historically, Depreciation & Amortization - Total has averaged $1583.3 across 3 years, with a median of $2000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization - Total soared 100.0% in 2024, then slumped 50.0% in 2025.
• Over 3 years, Depreciation & Amortization - Total stood at $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
• According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $2000.0, $1000.0, and $2000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.